Tag: Clinical Trials

84.7 percent of patients in clinical trials were White and 54.8 percent were men; underrepresentation seen in trials of nearly all phases

Eight barriers discussed include differential care, ageism, logistical barriers, lack of diversity in clinical trial leadership

However, there was a significant decrease in enrollment for cancer control and prevention trials

112 of the 253 authorized drugs have not been confirmed as clinically effective; 24 of these have been on market more than five years

Changes were recommended to preserve potential patient benefit while minimizing risks associated with COVID-19

Studies involving human genome editing should be made public, even though it would not necessarily stop unprincipled scientists

Overall, progression-free, and cancer-specific survival worse for participants from areas with highest socioeconomic deprivation

Ways to improve representation of African Americans in clinical trials could be extrapolated to other underrepresented groups

Significant inverse correlation identified between proportion of patients enrolled outside the U.S. and disparity score

While the treatment seemed safe, no significant differences in outcomes were seen between patients receiving convalescent plasma or placebo